You are here

  • Home
  • Archive
  • Volume 29, Issue 2
  • TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses

Article info

Article menu
Download PDFPDF
Original Article
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses

Authors

  1. Correspondence to Stephanie Lheureux, Division on Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada; stephanie.lheureux{at}uhn.ca
View Full Text

Citation

Mandilaras V, Garg S, Cabanero M, et al
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
International Journal of Gynecologic Cancer 2019;29:346-352.

Publication history

  • Received September 9, 2018
  • Revision received November 25, 2018
  • Accepted November 29, 2018
  • First published January 18, 2019.
Online issue publication 
August 17, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.